Austar Lifesciences Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
47.00
22.00
-45.00
127.00
371.00
34.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
52.00
28.00
-212.00
-288.00
-254.00
20.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
142.00
92.00
-153.00
-128.00
-69.00
107.00
Cash Flow from Investing Activities
-17.00
3.00
-65.00
-178.00
70.00
-75.00
Cash Flow from Financing Activities
-47.00
-91.00
177.00
150.00
76.00
-2.00
Net Cash Inflow / Outflow
77.00
5.00
-41.00
-154.00
78.00
29.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
1.00
0.00
1.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Austar Lifesciences Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
47.1745975796928
1891.30898239015
-1,844.00
-97.51%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
52.6297501344276
-623.485978688213
675.00
108.44%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
142.774248185522
1491.6610357555
-1,349.00
-90.43%
Cash Flow from Investing Activities
-17.3415286978548
-641.897931952971
624.00
97.30%
Cash Flow from Financing Activities
-47.6029843111282
-785.40423341373
738.00
93.94%
Net Cash Inflow / Outflow
77.1193723687152
72.90925264357
5.00
5.77%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-0.71036280782332
8.55038225477718
-8.00
-108.31%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is 54.29% vs 160.23% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
142.77
92.54
54.29%






